This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3nuu
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3nuu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3nuu OCA], [http://pdbe.org/3nuu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3nuu RCSB], [http://www.ebi.ac.uk/pdbsum/3nuu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3nuu ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3nuu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3nuu OCA], [http://pdbe.org/3nuu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3nuu RCSB], [http://www.ebi.ac.uk/pdbsum/3nuu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3nuu ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Fragment screening of phosphoinositide-dependent kinase-1 (PDK1) in a biochemical kinase assay afforded hits that were characterized and prioritized based on ligand efficiency and binding interactions with PDK1 as determined by NMR. Subsequent crystallography and follow-up screening led to the discovery of aminoindazole 19, a potent leadlike PDK1 inhibitor with high ligand efficiency. Well-defined structure-activity relationships and protein crystallography provide a basis for further elaboration and optimization of 19 as a PDK1 inhibitor. | ||
| + | |||
| + | Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery.,Medina JR, Blackledge CW, Heerding DA, Campobasso N, Ward P, Briand J, Wright L, Axten JM ACS Med Chem Lett. 2010 Jul 22;1(8):439-42. doi: 10.1021/ml100136n. eCollection, 2010 Nov 11. PMID:24900229<ref>PMID:24900229</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 3nuu" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
*[[3-phosphoinositide-dependent protein kinase 1|3-phosphoinositide-dependent protein kinase 1]] | *[[3-phosphoinositide-dependent protein kinase 1|3-phosphoinositide-dependent protein kinase 1]] | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
Revision as of 08:18, 10 October 2018
phosphoinositide-dependent kinase-1 (PDK1) with fragment11
| |||||||||||
